(Q53333126)

13 May 2018

title

Elevated plasma homocysteine level is not primarily related to Alzheimer's disease. (English)

1 reference

13 May 2018

author name string

Karin Nilsson

series ordinal

1

1 reference

13 May 2018

Lars Gustafson

series ordinal

2

1 reference

13 May 2018

Björn Hultberg

series ordinal

3

1 reference

13 May 2018

publication date

1 January 2012

1 reference

13 May 2018

Dementia and Geriatric Cognitive Disorders

published in

1 reference

13 May 2018

volume

34

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

page(s)

121-127

1 reference

13 May 2018

Hyperhomocysteinemia and Alzheimer's disease: A systematic review

cites work

1 reference

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

21 January 2018

1 reference

Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?

21 January 2018

1 reference

Facts and recommendations about total homocysteine determinations: an expert opinion

21 January 2018

1 reference

Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview

21 January 2018

1 reference

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

21 January 2018

1 reference

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

21 January 2018

1 reference

How common is vitamin B-12 deficiency?

21 January 2018

1 reference

The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases

21 January 2018

1 reference

One-carbon metabolism and Alzheimer's disease: focus on epigenetics

21 January 2018

1 reference

Plasma creatinine as a determinant of plasma total homocysteine concentrations in the Hordaland Homocysteine Study: use of statistical modeling to determine reference limits

21 January 2018

1 reference

Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering?

21 January 2018

1 reference

The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma cystatin C.

21 January 2018

1 reference

Plasma homocysteine, cobalamin/folate status, and vascular disease in a large population of psychogeriatric patients.

21 January 2018

1 reference

Elevated plasma homocysteine concentration in elderly patients with mental illness is mainly related to the presence of vascular disease and not the diagnosis.

21 January 2018

1 reference

Survival in a large elderly population of patients with dementia and other forms of psychogeriatric diseases.

21 January 2018

1 reference

Mild cognitive impairment as a diagnostic entity

21 January 2018

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

Folate deficiency is a common finding in psychogeriatric patients

21 January 2018

1 reference

Vitamin B12 and folate deficiency in later life

21 January 2018

1 reference

The use of N-terminal pro-brain natriuretic Peptide to evaluate vascular disease in elderly patients with mental illness

21 January 2018

1 reference

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.

21 January 2018

1 reference

Relation between plasma homocysteine and Alzheimer's disease

21 January 2018

1 reference

Plasma homocysteine is elevated in elderly patients with memory complaints and vascular disease

21 January 2018

1 reference

The rate of conversion of mild cognitive impairment to dementia: predictive role of depression.

21 January 2018

1 reference

Homocysteine, vitamin B12, folate and cognitive functions: a systematic and critical review of the literature.

21 January 2018

1 reference

High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial

21 January 2018

1 reference

Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial

21 January 2018

1 reference

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial

21 January 2018

1 reference

Mild cognitive impairment

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000342612

1 reference

13 May 2018

1 reference

13 May 2018